Solid tumor treating medicine composition
A tumor and solid technology, applied in the direction of drug combination, antineoplastic drugs, drug delivery, etc., can solve the problem of systemic toxicity and side effects that limit clinical application
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0053] Put 90 mg of medicinal excipient polylactic acid (PLA) with a molecular weight of 10000 into a container, add 100 ml of organic solvent to dissolve and mix with dichloromethane, add 10 mg of melphalan, shake again, and vacuum dry to remove the organic solvent. The dried solid composition is immediately shaped, and after packaging, it is ray sterilized to obtain a pharmaceutical composition for curing solid tumors containing 10% by weight of melphalan, which is used as a slow-release implant.
Embodiment 2
[0054] Example 2: As described in Example 1, the difference is that the components are one of the following, all of which are percentages by weight:
[0055] (A) 5-15% melphalan and 85-95% copolymer of polyglycolic acid and glycolic acid;
[0056] (B) 15-35% melphalan and 65-85% copolymer of polyglycolic acid and glycolic acid;
[0057] (C) 5-15% melphalan and 85-95% polylactic acid;
[0058] (D) 15-35% melphalan and 65-85% polylactic acid;
[0059] (E) 5-15% melphalan and 85-95% polystyrene;
[0060] (F) 15-35% melphalan and 65-85% polystyrene.
Embodiment 3
[0062] Put the weighing 85mg of medicinal excipient polylactic acid (PLA) with a molecular weight of 15000) into the container, add 100ml of organic solvent to dissolve in dichloromethane, add 15mg of melphalan, shake again and vacuum dry to remove the organic solvent . The dried solid composition is immediately shaped, and then irradiated to sterilize it after packaging to obtain a pharmaceutical composition for curing solid tumors containing 15% by weight of melphalan, which is used as a sustained-release implant.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 